SPARTOO (ALSPT.PA) Fundamental Analysis & Valuation

EPA:ALSPT • FR00140043Y1

0.245 EUR
+0.01 (+4.7%)
Last: Mar 5, 2026, 07:00 PM

This ALSPT.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ALSPT. ALSPT was compared to 59 industry peers in the Specialty Retail industry. ALSPT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALSPT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. ALSPT.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALSPT has reported negative net income.
  • ALSPT had a positive operating cash flow in the past year.
  • In multiple years ALSPT reported negative net income over the last 5 years.
  • In multiple years ALSPT reported negative operating cash flow during the last 5 years.
ALSPT.PA Yearly Net Income VS EBIT VS OCF VS FCFALSPT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 5M -5M -10M -15M -20M

1.2 Ratios

  • The Return On Assets of ALSPT (-2.58%) is worse than 67.80% of its industry peers.
  • ALSPT has a worse Return On Equity (-7.11%) than 69.49% of its industry peers.
  • With a decent Return On Invested Capital value of 11.65%, ALSPT is doing good in the industry, outperforming 79.66% of the companies in the same industry.
Industry RankSector Rank
ROA -2.58%
ROE -7.11%
ROIC 11.65%
ROA(3y)-3.05%
ROA(5y)-1%
ROE(3y)-9.05%
ROE(5y)-1.75%
ROIC(3y)N/A
ROIC(5y)N/A
ALSPT.PA Yearly ROA, ROE, ROICALSPT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • ALSPT's Operating Margin of 5.49% is fine compared to the rest of the industry. ALSPT outperforms 66.10% of its industry peers.
  • ALSPT's Operating Margin has improved in the last couple of years.
  • The Gross Margin of ALSPT (50.85%) is better than 72.88% of its industry peers.
  • In the last couple of years the Gross Margin of ALSPT has remained more or less at the same level.
Industry RankSector Rank
OM 5.49%
PM (TTM) N/A
GM 50.85%
OM growth 3Y26.27%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.43%
GM growth 5YN/A
ALSPT.PA Yearly Profit, Operating, Gross MarginsALSPT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 20 30 40 50

5

2. ALSPT.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ALSPT is creating value.
  • Compared to 1 year ago, ALSPT has more shares outstanding
  • Compared to 1 year ago, ALSPT has an improved debt to assets ratio.
ALSPT.PA Yearly Shares OutstandingALSPT.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M
ALSPT.PA Yearly Total Debt VS Total AssetsALSPT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • An Altman-Z score of 1.85 indicates that ALSPT is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • ALSPT has a Altman-Z score (1.85) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of ALSPT is 3.27, which is a good value as it means it would take ALSPT, 3.27 years of fcf income to pay off all of its debts.
  • ALSPT has a Debt to FCF ratio of 3.27. This is in the better half of the industry: ALSPT outperforms 67.80% of its industry peers.
  • A Debt/Equity ratio of 0.44 indicates that ALSPT is not too dependend on debt financing.
  • ALSPT has a Debt to Equity ratio (0.44) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 3.27
Altman-Z 1.85
ROIC/WACC2.11
WACC5.52%
ALSPT.PA Yearly LT Debt VS Equity VS FCFALSPT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

  • A Current Ratio of 1.95 indicates that ALSPT should not have too much problems paying its short term obligations.
  • ALSPT has a Current ratio of 1.95. This is amongst the best in the industry. ALSPT outperforms 83.05% of its industry peers.
  • A Quick Ratio of 0.65 indicates that ALSPT may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.65, ALSPT is in line with its industry, outperforming 57.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 0.65
ALSPT.PA Yearly Current Assets VS Current LiabilitesALSPT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M

2

3. ALSPT.PA Growth Analysis

3.1 Past

  • The earnings per share for ALSPT have decreased strongly by -57.86% in the last year.
  • The Revenue has decreased by -7.50% in the past year.
  • ALSPT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.60% yearly.
EPS 1Y (TTM)-57.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.57%
Revenue 1Y (TTM)-7.5%
Revenue growth 3Y-4.6%
Revenue growth 5YN/A
Sales Q2Q%-8.19%

3.2 Future

  • ALSPT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.51% yearly.
  • Based on estimates for the next years, ALSPT will show a decrease in Revenue. The Revenue will decrease by -2.67% on average per year.
EPS Next Y50%
EPS Next 2Y32.29%
EPS Next 3Y20.51%
EPS Next 5YN/A
Revenue Next Year-8.47%
Revenue Next 2Y-4.21%
Revenue Next 3Y-2.67%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALSPT.PA Yearly Revenue VS EstimatesALSPT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ALSPT.PA Yearly EPS VS EstimatesALSPT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 -0.2 -0.3

3

4. ALSPT.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALSPT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ALSPT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALSPT.PA Price Earnings VS Forward Price EarningsALSPT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALSPT indicates a rather cheap valuation: ALSPT is cheaper than 100.00% of the companies listed in the same industry.
  • ALSPT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ALSPT is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.84
EV/EBITDA 0.74
ALSPT.PA Per share dataALSPT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ALSPT's earnings are expected to grow with 20.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.29%
EPS Next 3Y20.51%

0

5. ALSPT.PA Dividend Analysis

5.1 Amount

  • ALSPT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ALSPT.PA Fundamentals: All Metrics, Ratios and Statistics

SPARTOO

EPA:ALSPT (3/5/2026, 7:00:00 PM)

0.245

+0.01 (+4.7%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners35.61%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.48M
Revenue(TTM)125.12M
Net Income(TTM)-2.05M
Analysts84.44
Price Target1.12 (357.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)37.5%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)60%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-0.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.04
P/FCF 0.84
P/OCF 0.76
P/B 0.16
P/tB 0.19
EV/EBITDA 0.74
EPS(TTM)-0.11
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)0.29
FCFY119.1%
OCF(TTM)0.32
OCFY130.78%
SpS6.84
BVpS1.58
TBVpS1.31
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.58%
ROE -7.11%
ROCE 15.85%
ROIC 11.65%
ROICexc 15.48%
ROICexgc 18.18%
OM 5.49%
PM (TTM) N/A
GM 50.85%
FCFM 4.26%
ROA(3y)-3.05%
ROA(5y)-1%
ROE(3y)-9.05%
ROE(5y)-1.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y13.91%
ROICexgc growth 5YN/A
ROICexc growth 3Y13.21%
ROICexc growth 5YN/A
OM growth 3Y26.27%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.43%
GM growth 5YN/A
F-Score6
Asset Turnover1.58
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 3.27
Debt/EBITDA 0.86
Cap/Depr 6.61%
Cap/Sales 0.42%
Interest Coverage 250
Cash Conversion 39.62%
Profit Quality N/A
Current Ratio 1.95
Quick Ratio 0.65
Altman-Z 1.85
F-Score6
WACC5.52%
ROIC/WACC2.11
Cap/Depr(3y)16.79%
Cap/Depr(5y)31.52%
Cap/Sales(3y)0.76%
Cap/Sales(5y)1.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.57%
EPS Next Y50%
EPS Next 2Y32.29%
EPS Next 3Y20.51%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.5%
Revenue growth 3Y-4.6%
Revenue growth 5YN/A
Sales Q2Q%-8.19%
Revenue Next Year-8.47%
Revenue Next 2Y-4.21%
Revenue Next 3Y-2.67%
Revenue Next 5YN/A
EBIT growth 1Y123.29%
EBIT growth 3Y20.46%
EBIT growth 5YN/A
EBIT Next Year363.16%
EBIT Next 3Y62.81%
EBIT Next 5YN/A
FCF growth 1Y135.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y142.61%
OCF growth 3YN/A
OCF growth 5YN/A

SPARTOO / ALSPT.PA FAQ

What is the fundamental rating for ALSPT stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALSPT.PA.


Can you provide the valuation status for SPARTOO?

ChartMill assigns a valuation rating of 3 / 10 to SPARTOO (ALSPT.PA). This can be considered as Overvalued.


Can you provide the profitability details for SPARTOO?

SPARTOO (ALSPT.PA) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for ALSPT stock?

The Earnings per Share (EPS) of SPARTOO (ALSPT.PA) is expected to grow by 50% in the next year.